1. Home
  2. ULS vs BIO Comparison

ULS vs BIO Comparison

Compare ULS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UL Solutions Inc.

ULS

UL Solutions Inc.

HOLD

Current Price

$80.36

Market Cap

15.4B

Sector

N/A

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$304.39

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULS
BIO
Founded
1894
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
15.4B
8.2B
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
ULS
BIO
Price
$80.36
$304.39
Analyst Decision
Buy
Strong Buy
Analyst Count
8
4
Target Price
$81.75
$358.50
AVG Volume (30 Days)
2.5M
146.2K
Earning Date
02-19-2026
02-12-2026
Dividend Yield
0.64%
N/A
EPS Growth
10.58
N/A
EPS
1.67
N/A
Revenue
$3,003,000,000.00
$2,557,500,000.00
Revenue This Year
$7.18
$1.62
Revenue Next Year
$5.56
$2.26
P/E Ratio
$48.44
N/A
Revenue Growth
6.68
N/A
52 Week Low
$48.54
$211.43
52 Week High
$91.95
$373.69

Technical Indicators

Market Signals
Indicator
ULS
BIO
Relative Strength Index (RSI) 50.22 47.59
Support Level $78.49 $300.26
Resistance Level $81.41 $305.62
Average True Range (ATR) 1.69 6.99
MACD 0.31 0.13
Stochastic Oscillator 73.12 53.56

Price Performance

Historical Comparison
ULS
BIO

About ULS UL Solutions Inc.

UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: